Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma

Avalere Essential Voice

English - February 12, 2021 15:04 - 12 minutes - 17 MB
Medicine Health & Fitness Science Life Sciences Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Avalere 2021 Healthcare Industry Outlook: Clearing the Path

Next Episode: Smart Food Policy for Healthy Food Labeling: Leading With Taste, Not Healthiness, to Shift Consumption and Enjoyment of Healthy Foods

In this episode of Avalere Health Essential Voice, our experts discuss recent research focused on patients who received CAR T-cell therapy for large B-cell lymphoma (LBCL) using Medicare fee-for-service claims data.